Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Sep-24 6:10 PM View:  | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-24 | Option Exercise | 9,034 | -- | -- | 8% 108.41K to 117.44K | |
| 12-Sep-24 6:13 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-24 | Option Exercise | 25,219 | -- | -- | 3% 807.9K to 833.12K | |
| 29-May-24 7:07 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-24 | Option Exercise | 25,219 | -- | -- | 3% 782.68K to 807.9K | |
| 29-May-24 7:12 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-24 | Option Exercise | 9,035 | -- | -- | 9% 99.38K to 108.41K | |
| 04-Mar-14 8:37 PM View: | Swisher Daniel N Jr President and CEO Director | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Feb-24 | Payment of Exercise | 3,747 | $6.55 | $24,542.90 | (1%) 260.9K to 257.15K | |
| 27-Feb-24 7:54 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 27-Feb-24 | Option Sale | 3,405 | $0.73 | $2,493.14 | (3%) 105.71K to 102.31K | |
| 27-Feb-24 7:54 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-24 | Option Exercise | 6,889 | -- | -- | 7% 98.82K to 105.71K | |
| 27-Feb-24 7:56 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-24 | Option Exercise | 9,034 | -- | -- | 10% 90.34K to 99.38K | |
| 27-Feb-24 7:58 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-24 | Option Exercise | 25,219 | -- | -- | 3% 757.46K to 782.68K | |
| 04-Dec-23 4:54 PM View: | Rothera Mark President and CEO Director | Sunesis Pharmaceuticals Inc. (VIRX) | 01-Dec-23 | Purchase | 47,906 | $0.49 | $23,627.20 | 92% 52.09K to 100.0K | |
| 04-Dec-23 4:54 PM View: | Rothera Mark President and CEO Director | Sunesis Pharmaceuticals Inc. (VIRX) | 30-Nov-23 | Private Purchase | 52,094 | $0.49 | $25,734.40 | 100% 0 to 52.09K | |
| 28-Nov-23 7:06 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Nov-23 | Option Sale | 3,720 | $0.50 | $1,860.00 | (4%) 102.54K to 98.82K | |
| 28-Nov-23 7:06 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-23 | Option Exercise | 6,889 | -- | -- | 7% 95.65K to 102.54K | |
| 28-Nov-23 7:01 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-23 | Option Exercise | 9,034 | -- | -- | 11% 81.31K to 90.34K | |
| 28-Nov-23 7:03 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-23 | Option Exercise | 25,219 | -- | -- | 3% 732.25K to 757.46K | |
| 29-Aug-23 6:47 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Aug-23 | Option Sale | 3,512 | $1.45 | $5,092.40 | (4%) 99.17K to 95.65K | |
| 29-Aug-23 6:52 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-23 | Option Exercise | 25,219 | -- | -- | 4% 707.03K to 732.25K | |
| 29-Aug-23 6:47 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-23 | Option Exercise | 6,888 | -- | -- | 7% 92.28K to 99.17K | |
| 29-Aug-23 6:49 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-23 | Option Exercise | 9,034 | -- | -- | 12% 72.27K to 81.31K | |
| 26-May-23 7:29 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-23 | Option Exercise | 6,889 | -- | -- | 8% 89.02K to 95.91K | |
| 26-May-23 7:29 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-23 | Option Sale | 3,635 | $1.42 | $5,160.25 | (4%) 95.91K to 92.28K | |
| 26-May-23 7:30 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-23 | Option Exercise | 9,035 | -- | -- | 14% 63.24K to 72.27K | |
| 26-May-23 7:32 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-23 | Option Exercise | 25,219 | -- | -- | 4% 681.81K to 707.03K | |
| 28-Feb-23 6:22 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 27-Feb-23 | Option Sale | 3,599 | $1.68 | $6,050.64 | (4%) 92.62K to 89.02K | |
| 28-Feb-23 6:28 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 27-Feb-23 | Option Sale | 2,156 | $1.68 | $3,624.67 | (4%) 50.24K to 48.09K | |
| 28-Feb-23 6:25 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-23 | Option Exercise | 9,034 | -- | -- | 17% 54.2K to 63.24K | |
| 28-Feb-23 6:28 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-23 | Option Exercise | 4,127 | -- | -- | 9% 46.12K to 50.24K | |
| 28-Feb-23 6:30 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-23 | Option Exercise | 25,219 | -- | -- | 4% 656.59K to 681.81K | |
| 28-Feb-23 6:22 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Feb-23 | Option Exercise | 6,889 | -- | -- | 8% 85.73K to 92.62K | |
| 29-Nov-22 5:33 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Nov-22 | Option Sale | 3,532 | $2.72 | $9,605.63 | (4%) 89.27K to 85.73K | |
| 29-Nov-22 5:25 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Nov-22 | Option Sale | 2,116 | $2.72 | $5,754.04 | (4%) 48.23K to 46.12K | |
| 29-Nov-22 5:25 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-22 | Option Exercise | 4,127 | -- | -- | 9% 44.1K to 48.23K | |
| 29-Nov-22 5:18 PM View: | Royston Ivor Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-22 | Option Exercise | 25,219 | -- | -- | 4% 631.37K to 656.59K | |
| 29-Nov-22 5:33 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-22 | Option Exercise | 6,889 | -- | -- | 8% 82.38K to 89.27K | |
| 29-Nov-22 5:21 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Nov-22 | Option Exercise | 9,034 | -- | -- | 20% 45.17K to 54.2K | |
| 29-Aug-22 9:14 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 26-Aug-22 | Option Sale | 3,655 | $4.02 | $14,679.20 | (4%) 86.03K to 82.38K | |
| 29-Aug-22 9:11 PM View: | Royston Ivor CEO & President Director | Sunesis Pharmaceuticals Inc. (VIRX) | 26-Aug-22 | Option Sale | 13,379 | $4.01 | $53,656.50 | (2%) 644.75K to 631.37K | |
| 29-Aug-22 9:18 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 26-Aug-22 | Option Sale | 2,190 | $4.01 | $8,785.84 | (5%) 46.3K to 44.1K | |
| 29-Aug-22 9:18 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-22 | Option Exercise | 4,127 | -- | -- | 10% 42.17K to 46.3K | |
| 29-Aug-22 9:11 PM View: | Royston Ivor CEO & President Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-22 | Option Exercise | 25,219 | -- | -- | 4% 619.53K to 644.75K | |
| 29-Aug-22 9:14 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-22 | Option Exercise | 6,889 | -- | -- | 9% 79.14K to 86.03K | |
| 29-Aug-22 9:16 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-Aug-22 | Option Exercise | 9,034 | -- | -- | 25% 36.14K to 45.17K | |
| 27-May-22 5:32 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 26-May-22 | Option Sale | 2,154 | $1.90 | $4,094.97 | (5%) 44.32K to 42.17K | |
| 27-May-22 5:27 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 26-May-22 | Option Sale | 3,596 | $1.90 | $6,836.36 | (4%) 82.74K to 79.14K | |
| 27-May-22 5:34 PM View: | Royston Ivor CEO & President Director | Sunesis Pharmaceuticals Inc. (VIRX) | 26-May-22 | Option Sale | 13,162 | $1.90 | $25,022.30 | (2%) 632.69K to 619.53K | |
| 27-May-22 10:00 PM View: | Pomerantz Roger Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-22 | Option Exercise | 9,034 | -- | -- | 33% 27.1K to 36.14K | |
| 27-May-22 5:32 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-22 | Option Exercise | 4,127 | -- | -- | 10% 40.2K to 44.32K | |
| 27-May-22 5:34 PM View: | Royston Ivor CEO & President Director | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-22 | Option Exercise | 25,219 | -- | -- | 4% 607.47K to 632.69K | |
| 27-May-22 5:27 PM View: | Chevallard Daniel R. CFO and COO | Sunesis Pharmaceuticals Inc. (VIRX) | 25-May-22 | Option Exercise | 6,889 | -- | -- | 9% 75.85K to 82.74K | |
| 01-Mar-22 9:12 PM View: | Rojkjaer Lisa Chief Medical Officer | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Feb-22 | Option Sale | 2,395 | $2.78 | $6,656.90 | (6%) 42.59K to 40.2K |
